Stock Screener - US Stocks, Forex and ETFs Please enable JavaScript to view this page content properly  
     
   MACD(12,26,9) Crossed Above Zero     
Criteria:
MACD(12,26,9) Crossed Above Zero
  Back to MACD Stock Screener
           
   Symbol   Name   Industry   Sector   Exchange  Cap, mln  Last  Change  Change, %  Volume
 ABEO    Abeona Therapeutics Inc  Biotechnology Healthcare NASDAQ 328  8.75  0.90 11.5 796,342
 ACC    American Campus Communities Inc  REIT - Residential Financial NYSE 6,469  47.69  -0.01 -0.021 540,550
 ACIA    Acacia Communications Inc  Communication Equipment Technology NASDAQ 1,730  45.06  2.35 5.5 731,823
 ACST    Acasti Pharma Inc  Biotechnology Healthcare NASDAQ 19  1.32  0.03 2.3 10,410
 ADES    Akasha Wira International Tbk PT  Pollution & Treatment Controls Industrial Goods NASDAQ 203  10.11  0.19 1.9 103,063
 AES    AES Corp  Electric Utilities Utilities NYSE 7,269  11.35  0.00 0.00 2,906,285
 AMBA    Ambarella Inc  Semiconductor Equipment & Materials Technology NASDAQ 1,700  53.30  1.63 3.2 679,224
 ANDAW    Andina Acquisition Corporation    NASDAQ   0.32  0.04 14.3 24,379
 ANGL    VanEck Vectors Fallen Angel High Yield Bond ETF  Exchange Traded Fund Financial NYSE   29.84  0.06 0.2 308,589
 ANTX    Anthem Inc  Health Care Plans Healthcare NYSE 1,298  52.35  -0.08 -0.2 62,257
Please sign up for viewing the full list of stocks


Education MACD - Technical Analysis from A to Z
The MACD (Moving Average Convergence/Divergence) is a trend following momentum indicator that shows the relationship between two moving averages of prices. The MACD is the difference between a 26-day and 12-day exponential moving average. A 9-day exponential moving average, called the "signal" line is plotted on top of the MACD to show buy/sell opportunities. The MACD proves most effective in wide-swinging trading markets. There are three popular ways to use the MACD: crossovers, overbought/oversold conditions, and divergences. Learn more




Disclaimer - FAQ - Contact Us
Copyright ©2008-2017 Market In&Out. All rights reserved.
Best viewed in